Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 3
2013 1
2014 4
2015 5
2016 11
2017 6
2018 3
2019 3
2020 6
2021 9
2022 6
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Mobile infrared slit-light scanner for rapid eye disease screening.
Kaushik N, Sharma P, Himori N, Matsumoto T, Miya T, Nakazawa T. Kaushik N, et al. Among authors: matsumoto t. J Med Imaging (Bellingham). 2024 Mar;11(2):026003. doi: 10.1117/1.JMI.11.2.026003. Epub 2024 Apr 10. J Med Imaging (Bellingham). 2024. PMID: 38606184
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y, Kanemura N, Nakamura N, Ikoma Y, Yamaguchi K, Takada E, Shibata Y, Lee S, Fujita K, Morishita T, Matsumoto T, Nakamura H, Kitagawa J, Kasahara S, Hara T, Tsurumi H, Shimizu M. Kaneda Y, et al. Among authors: matsumoto t. Leuk Lymphoma. 2024 Mar;65(3):339-345. doi: 10.1080/10428194.2023.2295787. Epub 2023 Dec 20. Leuk Lymphoma. 2024. PMID: 38124378
A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma.
Ikoma Y, Nakamura N, Kitagawa J, Miwa T, Takada E, Matsumoto T, Shibata Y, Nakamura H, Kanemura N, Kasahara S, Hara T, Sawada M, Tsurumi H, Shimizu M. Ikoma Y, et al. Among authors: matsumoto t. Hematol Oncol. 2024 Jan;42(1):e3236. doi: 10.1002/hon.3236. Epub 2023 Nov 6. Hematol Oncol. 2024. PMID: 37932900 Clinical Trial.
Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
Nakamura N, Kanemura N, Matsumoto T, Nakamura H, Ikoma Y, Shibata Y, Kitagawa J, Kasahara S, Yamada T, Sawada M, Kaneda Y, Fukuno K, Takada E, Goto H, Lee S, Fujita K, Morishita T, Hara T, Tsurumi H, Shimizu M. Nakamura N, et al. Among authors: matsumoto t. Sci Rep. 2023 Nov 4;13(1):19060. doi: 10.1038/s41598-023-46501-5. Sci Rep. 2023. PMID: 37925551 Free PMC article.
The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8+ T Cells and Clinical Outcomes in Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer.
Nakajima S, Kaneta A, Okayama H, Saito K, Kikuchi T, Endo E, Matsumoto T, Fukai S, Sakuma M, Sato T, Mimura K, Saito M, Saze Z, Sakamoto W, Onozawa H, Momma T, Kono K. Nakajima S, et al. Among authors: matsumoto t. Cancers (Basel). 2023 May 18;15(10):2826. doi: 10.3390/cancers15102826. Cancers (Basel). 2023. PMID: 37345163 Free PMC article.
60 results